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Summary
The shortage of oil resources, the steadily rising oil
prices and the impact of its use on the environment
evokes an increasing political, industrial and techni-
cal interest for development of safe and efficient proc-
esses for the production of chemicals from renewable
biomass. Thus, microbial fermentation of renewable
feedstocks found its way in white biotechnology,
complementing more and more traditional crude oil-
based chemical processes. Rational strain design of
appropriate microorganisms has become possible
due to steadily increasing knowledge on metabolism
and pathway regulation of industrially relevant organ-
isms and, aside from process engineering and opti-
mization, has an outstanding impact on improving
the performance of such hosts. Corynebacterium
glutamicum is well known as workhorse for the indus-
trial production of numerous amino acids. However,
recent studies also explored the usefulness of this
organism for the production of several organic acids
and great efforts have been made for improvement of
the performance. This review summarizes the current
knowledge and recent achievements on metabolic
engineering approaches to tailor C. glutamicum for
the bio-based production of organic acids. We focus
here on the fermentative production of pyruvate, L-
and D-lactate, 2-ketoisovalerate, 2-ketoglutarate, and
succinate. These organic acids represent a class of
compounds with manifold application ranges, e.g. in
pharmaceutical and cosmetics industry, as food addi-
tives, and economically very interesting, as precur-
sors for a variety of bulk chemicals and commercially
important polymers.
Introduction
The depletion of earth’s fossil energy resources, accom-
panied by the strong impact of their use on the environ-
ment, particularly in form of higher CO2 emissions, raises
the demand and the consumer pull for sustainable, safe
and efficient substitution of hitherto crude oil derived
chemicals and chemical building blocks from renewable
resources. Besides chemical manufacturing of renewable
feedstocks to valuable compounds, biotechnological
processes afford more and more opportunities to produce
fuels, building blocks, and solvents in a cost-effective way
from biomass (Bozell and Petersen, 2010). Chemical
buildings blocks, such as some organic acids, serve as
precursors for a variety of bulk chemicals and commer-
cially important polymers (Werpy and Petersen, 2004).
The cost-effective bio-based production of these chemi-
cals is a most relevant goal for the future and has to meet
economic and environmental requirements. Therefore,
the microbial production systems have to perform excel-
lent with regard to yield, productivity, product purity and
flexibility to substrate consumption.
Corynebacterium glutamicum is a Gram-positive facul-
tative anaerobic organism that grows on a variety of
sugars, organic acids, and alcohols as single or combined
carbon and energy sources (Eggeling and Bott, 2005;
Liebl, 2006; Nishimura et al., 2007; Takeno et al., 2007).
The organism is generally regarded as safe (GRAS
status) and is traditionally employed for large scale pro-
duction of amino acids, such as L-glutamate (> 2 million
t/a) and L-lysine (> 1.4 million t/a) (Eggeling and Bott,
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2005; Takors et al., 2007; Ajinomoto, 2010; 2011). In order
to improve the production performance by metabolic engi-
neering approaches, the central carbon metabolism, the
physiology and the regulation of main and specific path-
ways of C. glutamicum were analysed in detail and
genetic tools as well as systems biology approaches on
the ‘omics’ level have been developed and employed
(overviews in Kirchner and Tauch, 2003; Eggeling and
Bott, 2005; Sauer and Eikmanns, 2005; Wendisch et al.,
2006a; Bott, 2007; Takors et al., 2007; Burkowski, 2008;
Brinkrolf et al., 2010; Becker and Wittmann, 2011; Ter-
amoto et al., 2011; Vertes et al., 2012). Since C. glutami-
cum is regarded as a robust and easily manageable
production host, recent studies also focused on the suit-
ability of this organism for the production of other com-
modity chemicals, such as the biofuels isobutanol and
ethanol (Inui et al., 2004b; Smith et al., 2010; Blombach
and Eikmanns, 2011; Blombach et al., 2011), the
diamines cadaverine and putrescine (Mimitsuka et al.,
2007; Schneider and Wendisch, 2010; 2011; Kind et al.,
2010a,b; Kind and Wittmann, 2011), the sugar alcohol
xylitol (Sasaki et al., 2010), gamma-amino butyric acid
(Takahashi et al., 2012), polyhodroxybutyrate (Song
et al., 2012), and also several organic acids (reviewed in
this article).
Six years ago, Wendisch and colleagues (2006b)
reviewed the metabolic engineering of C. glutamicum and
Escherichia coli for the biotechnological production of
organic acids and amino acids. At that time, E. coli was
the superior platform organism for the production of
organic acids and it was hardly known that C. glutamicum
forms lactate and succinate under oxygen-deprivation
conditions (Dominguez et al., 1993; Inui et al., 2004a;
Okino et al., 2005). However, it was foreseeable that
genetically modified C. glutamicum strains will become
promising biocatalysts for the production of at least some
organic acids. As outlined in the following, great efforts
have been made in the last 7 years to successfully imple-
ment and/or to improve the production of several organic
acids with C. glutamicum. This review focuses on the
metabolic/genetic engineering approaches to tailor
C. glutamicum for the fermentative production of pyru-
vate, D- and L-lactate, 2-ketoisovalerate, 2-ketoglutarate,
and succinate from renewable carbon sources. Figure 1
gives an overview on pathways and enzymes of the
central metabolism of C. glutamicum, including the path-
ways for the degradation of selected substrates and those
for the synthesis of organic acids produced with this
organism.
Production of pyruvate
Pyruvate is broadly used as ingredient or additive in food,
cosmetics and pharmaceuticals, but also for the synthesis
of various chemicals and polymers (Li et al., 2001; Zhu
et al., 2008). Chemical production of pyruvate is realized
by dehydration and decarboxylation of tartaric acid, but in
a cost-ineffective way (Howard and Fraser, 1932; Li et al.,
2001). Different approaches were made for pyruvate
production with eukaryotic microorganisms like multi-
auxotrophic yeasts (reviewed in Li et al., 2001); however,
prokaryotic microorganisms, such as E. coli and
C. glutamicum, also were successfully engineered to
produce pyruvate.
Pyruvate is a central intermediate in the carbon and
energy metabolism (see Fig. 1) in all organisms and
thus, for construction of an efficient pyruvate-producing
C. glutamicum strain, the major pyruvate-drawing reac-
tions had to be downregulated or even eliminated. In the
course of the molecular analysis of the pyruvate dehydro-
genase complex (PDHC), Schreiner and colleagues
(2005) inactivated this complex in C. glutamicum by dele-
tion of the aceE gene, encoding the E1p subunit of the
PDHC. The resulting strain C. glutamicum DaceE required
acetate or ethanol as an additional carbon source for
growth on glucose (Schreiner et al., 2005; Blombach
et al., 2009). In an approach to engineer C. glutamicum
for L-valine production, Blombach and colleagues (2007)
observed that C. glutamicum DaceE showed a relatively
high intracellular concentration of pyruvate and, when
acetate was exhausted from the medium and growth
stopped, secreted significant amounts of L-alanine
(30 mM), L-valine (30 mM), and pyruvate (30 mM) from
glucose. In subsequent studies, the PDHC-deficient strain
turned out to be an excellent starting point to engineer
C. glutamicum for the efficient production of L-valine
(Blombach et al., 2007; 2008; 2009; Krause et al., 2009),
isobutanol (Blombach et al., 2011), and also of 2-
ketoisovalerate (Krause et al., 2010; see below), succi-
nate (see below) and pyruvate. The additional inactivation
of the pyruvate:quinone oxidoreductase (PQO) and
NADH-dependent L-lactate dehydrogenase (L-LDH)
significantly improved pyruvate formation (Wieschalka
et al., 2012). In shake-flask experiments, C. glutamicum
DaceE Dpqo DldhA accumulated in a growth-decoupled
manner about 50 mM pyruvate with a substrate-specific
product yield (YP/S) of 0.48 mol per mol of glucose, aside
from L-alanine (29 mM) and L-valine (21 mM) as
by-products (Wieschalka et al., 2012). To abolish overflow
metabolism towards L-valine, the native acetohydroxyacid
synthase (AHAS) was substituted by a leaky variant
(DC-T IlvN) leading to an almost threefold increased YP/S
of 1.36 mol pyruvate per mol of glucose, and a strong
increase of pyruvate production (up to 193 mM), while
L-valine and L-alanine formation were reduced to 1 mM
and 9 mM respectively (Wieschalka et al., 2012). Addi-
tional deletion of the genes encoding alanine aminotrans-
ferase (AlaT) and valine-pyruvate aminotransferase
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Fig. 1. Schematic presentation of the central carbon metabolism of C. glutamicum including pathways for the degradation of carbon sources
(glucose, glycerol, D-cellobiose, L-arabinose, D-xylose, mannose, formate, acetate) used for the production of pyruvate, D,L-lactate,
2-ketoisovalerate, 2-ketoglutarate and succinate. Ellipses represent enzymes and transport systems present in C. glutamicum. Rectangles
represent heterologous enzymes. Abbreviations: Coding genes are given in brackets. 6PG, 6P-gluconate; 6PGDH (gnd), 6PG dehydrogenase;
AHAIR (ilvC), acetohydroxyacid isomeroreductase; AHAS (ilvBN), acetohydroxyacid synthase; AK (ack), acetate kinase; AlaT (alaT), alanine
aminotransferase; AraA (araA from E. coli), arabinose isomerase; AraB (araB from E. coli), ribulokinase; AraD (araD from E. coli), L-ribulose-5-
phosphate 4-epimerase; AraE (araE from E. coli), L-arabinose transporter; AvtA (avtA), valine-pyruvate aminotransferase; BglA (bglA1, bglA2),
phospho-b-glucosidases; BglF (bglFV317A), mutated PTS permease enabling D-cellobiose import; CtfA (cat), CoA transferase A; DHAD (ilvD),
dihydroxyacid dehydratase; DHAP, dihydroxyacetone-P; F1,6P, fructose-1,6P; F6P, fructose-6P; FDH (fdh from Mycobacterium vaccae),
formate dehydrogenase; Fum (fum), fumarase; GAP, glyceraldehyde-3P; GAPDH (gapA), GAP dehydrogenase; GlpD (glpD from E. coli),
glycerol-3P dehydrogenase; GlpF (glpF from E. coli), glycerol facilitator; GlpK (glpK from E. coli), glycerol kinase; G6P, glucose-6P; G6PDH
(zwf, opcA), G6P dehydrogenase; ICD (icd), isocitrate dehydrogenase; ICL (aceA), isocitrate lyase; LDH (native ldhA or ldhA from L. del-
brueckii), L- and D-lactate dehydrogenase respectively; MalE (malE), malic enzyme; MctC (mctC) monocarboxylic acid transporter; Mdh (mdh),
malate dehydrogenase; MQO (mqo), malate:quinone oxidoreductase; MS (aceB), malate synthase; ODHC (odhA, aceF, lpd), 2-oxoglutarate
dehydrogenase complex; ODx (odx), oxaloacetate decarboxylase; PCx (pyc), pyruvate carboxylase; P, phosphate; PDHC (aceE, aceF, lpd),
pyruvate dehydrogenase complex; PEP phosphoenolpyruvate; PEPCk (pck), PEP carboxykinase; PEPCx (ppc), PEP carboxylase; Pyk (pyk),
pyruvate kinase; PMI (manA), phosphomannose isomerase; PQO (pqo), pyruvate: quinone oxidoreductase; PTA (pta), phosphotransacetylase;
PTS (ptsG, hpr; ptsI), phosphotransferase system; Rpe (rpe), ribulose-5-phosphate epimerase; SDH (sdhABC), succinate dehydrogenase;
TA (ilvE), transaminase B; XylA (xylA from E. coli), xylose isomerase; XylB (xylB from E. coli), xylulokinase.
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(AvtA) resulted in cumulative reduction of L-alanine as
undesired by-product by 50% (Wieschalka et al., 2012).
With the final strain C. glutamicum DaceE Dpqo DldhA
DC-T ilvN DalaT DavtA (designated as C. glutamicum
ELB-P; see Fig. 2) up to 200 mM pyruvate were formed in
shake-flask experiments, with a YP/S of 1.49 mol per mol of
glucose. The yields of the by-products L-alanine and
L-valine were evanescent low with 0.03 and 0.01 mol
per mol of glucose respectively (Wieschalka et al., 2012).
To study the relevance for industrial applications, fed-
batch fermentations were performed with C. glutamicum
ELB-P. When C. glutamicum ELB-P was cultivated with a
constant pO2 of about 30% a twofold lower glucose con-
sumption rate (0.28 mmol g cell dry weight (CDW)-1 h-1) and
a significantly lower YP/S (0.8 mol pyruvate per mol of
glucose) were observed when compared with shake-
flask experiments (0.58 mmol g(CDW)-1 h-1 and 1.49 mol
pyruvate per mol of glucose respectively). Implementation
of low oxygen tension from the middle until the end of
growth phase restored the production performance
and led to the formation of more than 500 mM (45 g l-1)
pyruvate with a YP/S of 0.97 mol pyruvate per mol of
glucose in the production phase (Wieschalka et al., 2012).
In comparison, the best pyruvate-producing E. coli strains
(E. coli YYC202 and ALS1059) produced under optimized
process conditions about 720 mM (63 g l-1) and 1 M
(90 g l-1) pyruvate, with YP/S of 1.74 and 1.39 mol pyruvate
per mol of glucose respectively (Zelic et al., 2003;
Zhu et al., 2008). Since the yield of C. glutamicum
ELB-P in shake-flask experiments is in the same
range as in these E. coli strains, further process optimi-
zation might disclose the whole potential of C. glutamicum
ELB-P for a further improved pyruvate production
process.
Fig. 2. Schematic presentation of the central carbon metabolism of C. glutamicum ELB-P with the corresponding enzymes and modifications,
leading to pyruvate production under aerobic conditions and reductive succinate production under anaerobic conditions. For most abbrevia-
tions see legend to Fig. 1. Further abbreviations: BCAAs, branched-chain amino acids; LdhA, NAD+-dependent L-lactate dehydrogenase;
SucE, succinate exporter; TCA, tricarboxylic acid. Down arrow at AHAS indicates decreased activity of the truncated AHAS derivative, crosses
indicate inactivation of the enzyme by deletion of the respective gene. Dotted arrows indicate pathways not present due to gene inactivation,
grey arrows indicate pathways not used in C. glutamicum ELB-P.
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Production of lactate
Lactate is widely used as both D- and L-isomers for phar-
maceutical, cosmetic, leather and textile, chemical, bio-
medical and food industries, as well as for green solvent
and biodegradable fibre and polymer production (Hofven-
dahl and Hahn-Hägerdal, 2000; Bozell and Petersen,
2010; Okano et al., 2010). Especially the latter, in form of
the stereocomplex of D- and L-polylactic acid is a fully
biodegradable substitute for polyethylene terephthalates
with high melting temperatures and mechanical strength,
and therefore, of great economical interest (Lorenz and
Zinke, 2005; Dodds and Gross, 2007; Fukushima et al.,
2007; Uehara et al., 2010). In the past and still today,
wild-type and recombinant lactic acid bacteria have
been mainly employed for the production of both D- and
L-lactate (reviewed in Okano et al., 2010). However, these
bacteria have a demand for complex media, which makes
the cultivation of the organisms and the purification of the
product relatively cost-intensive. Therefore, other less fas-
tidious organisms, such as metabolically engineered
E. coli, Saccharomyces cerevisiae and C. glutamicum
have also been developed for efficient L- and D-lactic acid
production (Okano et al., 2010).
Corynebacterium glutamicum is facultatively anaerobic
and grows aerobically and anaerobically in the presence
of oxygen and nitrate respectively (Nishimura et al., 2007;
Takeno et al., 2007). The lack of oxygen or nitrate as
external electron acceptors results in growth arrested
cells, which still have the capability to ferment C6 sugars
to L-lactate and succinate as major products. Dominguez
and colleagues (1993) firstly reported that C. glutamicum
forms lactate, succinate and acetate at small amounts
when oxygen is limited during aerobic growth. Inui and
colleagues (2004a) further studied this phenomenon in an
attempt to utilize corynebacterial properties for the indus-
trial production of lactate and succinate. These authors
reported of organic acid production with C. glutamicum
strain R and described that the bacteria showed no
growth under oxygen-deprivation conditions, but pro-
duced significant amounts of L-lactate (~ 220 mM) and
succinate (~ 20 mM) from about 130 mM glucose. Addi-
tion of bicarbonate to the medium led to an increase of the
NAD+/NADH ratio and, probably as consequence of a
derepression of the glyceraldehyde-3-phosphate dehy-
drogenase gene gapA, to an increased glucose consump-
tion (Inui et al., 2004a). Furthermore, the addition of
bicarbonate led to an altered product spectrum, i.e. the
formation of succinate and lactate increased by a factor of
two to four and significant concentrations (about 10 mM)
of acetate were formed (Inui et al., 2004a; Okino et al.,
2005). In a high cell density [30 g dry cell weight (DCW) l-1]
fed-batch system, C. glutamicum R already produced
574 mM L-lactate (i.e. 53 g l-1), with only small amounts
(< 10 mM) of succinate and acetate as side-products
(Okino et al., 2005). Addition of 400 mM bicarbonate
raised the L-lactate concentration to more than 1 M
(97.5 g l-1), but also the concentrations of the by-products
succinate (192 mM) and acetate (50 mM) (Okino et al.,
2005). Even without genetic modification of C. glutami-
cum, the resulting L-lactate titre from glucose and the YP/S
of 1.79 mol L-lactate per mol of glucose (i.e. 0.90 g g-1)
are highly competitive as e.g. the best known metaboli-
cally engineered L-lactate-producing E. coli strain SZ85
(pflB, frdBC, adhE, ackA, ldhA::ldhL, overexpressed ldhL
gene from Pediococcus acidilactici) accumulated 505 mM
L-lactate (i.e. 46 g l-1) with an optical purity of > 99% and
a YP/S of 1.9 mol per mol of glucose (i.e. 0.95 g g-1; Zhou
et al., 2003b) (see Table 1).
For D-lactate production with C. glutamicum, a L-LDH-
deficient mutant was constructed, expressing the
D-lactate dehydrogenase (D-LDH) from Lactobacillus
delbrueckii (Okino et al., 2008b). Under oxygen-
deprivation conditions, this mutant (C. glutamicum R
DldhA/pCRB204) produced in a high cell density system
(60 g(DCW) l-1) about 1.34 M D-lactate (i.e. 120 g l-1) within
30 h with an optical purity of > 99.9% and a YP/S of 1.73
mol per mol of glucose. But also significant amounts of
succinate (146 mM) and actetate (52 mM) were formed,
underlining product purity as major problem (Okino et al.,
2008b). However, C. glutamicum R DldhA/pCRB204 pro-
duced more D-lactate than E. coli JP203 (pta, ppc)
(Chang et al., 1999) and SZ63 (W3110; pflB, frdBC, adhE,
ackA) (Zhou et al., 2003a) (Table 1), the best known
genetically defined D-lactate producing E. coli strains, har-
bouring the native D-LDH of E. coli. With about 690 mM
(62 g l-1) and 530 mM (48 g l-1), these strains formed
approximately half of the titre obtained with C. glutamicum
R DldhA/pCRB204, however, with comparable YP/S of
between 1.76 and 1.92 mol D-lactate per mol of glucose
(0.90–0.99 g D-lactate per g of glucose; Chang et al.,
1999; Zhou et al., 2003a).
It has to be noted that all described C. glutamicum and
E. coli processes have to compete with those using
recombinant yeast strains (Saccharomyces and Kluyvero-
myces) that produce L-lactic acid with titres of up to 1.3 M,
optical purity of > 99.9%, and YP/S of up to 1.6 mol
L-lactate per mol of glucose (Saitoh et al., 2005; Okano
et al., 2010).
Production of 2-ketoisovalerate and 2-ketoglutarate
In nature, 2-ketoisovalerate (3-methyl-2-oxobutanoic
acid) is a precursor for L-valine, L-leucine, and pantothen-
ate synthesis in bacteria and plants. In these organisms,
it is formed from two molecules of pyruvate via the
reactions catalysed by AHAS, acetohydroxyacid isomer-
oreductase (AHAIR), and dihydroxyacid dehydratase
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(DHAD) (see Fig. 1). 2-Ketoisovalerate is used as substi-
tute for L-valine or L-leucine in chronic kidney disease
patients (Teschan et al., 1998; Feiten et al., 2005; Apari-
cio et al., 2009; 2012) and also has been used in therapy
for uremic hyperphosphatemia (Schaefer et al., 1994). To
our knowledge, 2-ketoisovalerate for these purposes is
mainly synthesized chemically by different methods
(Cooper et al., 1983) and only very recently, directed fer-
mentative production of 2-ketoisovalerate with microor-
ganisms has been reported for the first time (Krause et al.,
2010; see below).
Since 2-ketoisovalerate stems from two molecules of
pyruvate (see Fig. 1) and a PDHC-deficient C. glutami-
cum secreted significant amounts of pyruvate and
L-valine (see above), C. glutamicum DaceE was an
excellent basis to engineer C. glutamicum for the produc-
tion of this 2-ketoacid. To avoid transamination of
2-ketoisovalerate to L-valine, the ilvE gene encoding
transaminase B was deleted, leading to an auxotrophy
for branched chain amino acids. Aerobically, C. glutami-
cum DaceE DilvE formed about 76 mM pyruvate, 25 mM
L-alanine, and 40 mM 2-ketoisovalerate in a growth-
decoupled manner from glucose (Krause et al., 2010).
Overexpression of the AHAS, AHAIR and DHAD genes
shifted the product spectrum towards 2-ketoisovalerate
and the resulting strain C. glutamicum DaceE DilvE
(pJC4ilvBNCD) produced in fed-batch fermentations
about 85 mM 2-ketoisovalerate with a volumetric produc-
tivity of 1.9 mM h-1 and a YP/S of about 0.38 mol per mol
of glucose. Although the PQO has been found to be
dispensable for growth and a deletion was only slightly
beneficial on L-valine production (Schreiner et al., 2006;
Blombach et al., 2008), PQO inactivation turned out to
be highly beneficial for 2-ketoisovalerate production.
Compared with the parental strain, C. glutamicum DaceE
DilvE Dpqo (pJC4ilvBNCD) showed in fed-batch fermen-
tations more than two times higher final titres (up to
220 mM = 25.5 g l-1) and volumetric productivities of
4.6 mM h-1 (Krause et al., 2010; Table 1).
It is noteworthy to mention that the 2-ketoisovalerate-
producer C. glutamicum DaceE DilvE Dpqo
(pJC4ilvBNCD) was used as a basis for the generation of
a series of C. glutamicum strains producing isobutanol via
the so-called ‘Ehrlich pathway’ (Blombach and Eikmanns,
2011; Blombach et al., 2011). The most promising strain
of this series, C. glutamicum Iso7, carries additional dele-
tions of the L-LDH and malate dehydrogenase genes
(DldhA and Dmdh respectively) and overexpresses addi-
tionally the E. coli transhydrogenase genes pntAB, the
Lactococcus lactis ketoacid decarboxylase gene kivD,
and the homologous alcohol dehydrogenase gene adhA
(Blombach et al., 2011).
2-Ketoglutarate is an intermediate of the tricarboxylic
acid (TCA) cycle and the precursor for the synthesis of
glutamate and the glutamate family of amino acids.
2-Ketoglutarate is used in dairy industry (Banks et al.,
2001; Gutiérrez-Mendéz et al., 2008) and also is suitable
to treat chronic renal insufficiency in hemodialysis
patients (Riedel et al., 1996). An enzymatic process to
synthesize 2-ketoglutarate from glutamate via the coupled
reactions of glutamate dehydrogenase and NADH
oxidase has been established (Ödmann et al., 2004),
however, this bioconversion seems not very efficient.
Therefore, Jo and colleagues (2012) very recently used a
glutamate-overproducing mutant of C. glutamicum for
the construction of a 2-ketoglutarate-producer. Inactiva-
tion of the genes encoding glutamate dehydrogenase,
glutamate synthase and isocitrate lyase (gdh, gltB, and
aceA respectively) led to a drastic reduction of glutamate
formation (< 10 mM) and concomitantly to 2-ketoglutarate
accumulation to concentrations of up to 325 mM
(47.5 g l-1) after 120 h of cultivation in medium containing
glucose, molasses, glutamate, and soybean hydrolysate
(Jo et al., 2012). To our knowledge, there were no other
approaches to produce 2-ketoglutarate by fermentation
with any other bacterium. However, Zhou and colleagues
(2012) recently reported efficient 2-ketoglutarate produc-
tion (up to about 380 mM) with a recombinant (‘non-
conventional’) yeast strain of Yarrowia lipolytica with
enhanced acetyl-CoA availability.
Production of succinate
The C4 dicarboxylate succinate has been denoted as ‘a
LEGO® of chemical industry’ (Sauer et al., 2008) and as
such, can be used as precursor for known petrochemical
bulk products, such as 1,4-butanediol, tetrahydrofuran,
g-butyrolactone, adipic acid, maleic anhydride, various
n-pyrrolidinones, and linear aliphatic esters (Zeikus et al.,
1999; Sauer et al., 2008; Bozell and Petersen, 2010).
Moreover, succinate (or succinic acid) is directly used as
surfactant, ion chelator, and as an additive in pharmaceu-
tical, and food industry (McKinlay et al., 2007). The
market potential for succinic acid and its direct derivatives
has been estimated to be 245 000 tons per year, that for
succinic acid-derived polymers about 25 000 000 tons per
year, and with the transition to cost-efficient bio-based
production of succinate or succinic acid, the market is
predicted to steadily increase (Werpy and Petersen, 2004;
Bozell and Petersen, 2010).
Aside from L-lactate and acetate, succinate is a natural
fermentative end-product of the wild type of C. glutami-
cum, when incubated with glucose under oxygen depriva-
tion (Dominguez et al., 1993; Inui et al., 2004a). Under
these conditions, succinate is formed via glycolysis, car-
boxylation of phosphoenolpyruvate (PEP) or pyruvate to
oxaloacetate (OAA) by PEP carboxylase (PEPCx) and/or
pyruvate carboxylase (PCx), and subsequent conversion
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of OAA by malate dehydrogenase (Mdh), fumarase
(Fum), and succinate dehydrogenase (SDH) (Inui et al.,
2004a; see Fig. 1).
A two-stage succinate production process with
C. glutamicum strain R was developed by Okino and
colleagues (2008a), using a derivative devoid of LDH
activity and overexpressing the native PCx gene (pyc),
C. glutamicum R DldhA pCRA717. In a first step, cells of
this strain were grown under fully aerobic conditions.
Then, the cells were harvested, washed and transferred
to closed bottles, to give a high cell density of about
50 g(DCW) l-1. With repeated intermittent addition of glucose
and sodium bicarbonate, a final titre of 1.24 M succinate
(146 g l-1) was obtained within 46 h, with a YP/S of 1.4 mol
per mol of glucose (Okino et al., 2008a). The cells did not
form any lactate; however, they produced significant
amounts of acetate (0.3 M = 16 g l-1) as by-product.
Recently, also Litsanov and colleagues (2012b) engi-
neered C. glutamicum ATCC 13032 for high yield succi-
nate production by further extending the experimental
approach by Okino et al. (see above). Deletion of the LDH
gene, chromosomal integration of an allele for a deregu-
lated PCx (pycP458S) and deletion of the genes encoding
enzymes responsible for acetate synthesis (Dcat, Dpqo,
Dpta-ack) resulted in C. glutamicum BOL-2, that produces
up to 116 mM succinate with a YP/S of 1.03 mol per mol of
glucose, and pyruvate (23 mM) as well as 2-ketoglutarate
(12 mM) as major by-products (Litsanov et al., 2012b). To
increase NADH and CO2 availability and to increase the
glycolytic flux, the authors then integrated the formate
dehydrogenase gene fdh from Mycobacterium vaccae
into the genome of C. glutamicum BOL-2 and addi-
tionally overexpressed the homologous glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) gene (gapA) from
plasmid. In a fed-batch fermentation with glucose, formate
and bicarbonate as substrates, the ultimate strain
C. glutamicum BOL-3/pAN6-gap (see Fig. 3) produced
1.13 M succinate (134 g l-1) with a YP/S of 1.67 mol per mol
of glucose (Litsanov et al., 2012b). Aside from succi-
nate, 2-ketoglutarate (35 mM), malate (33 mM), acetate
(20 mM), fumarate (13 mM), and pyruvate (6 mM) were
formed as by-products.
In a further approach, the pyruvate-producing strain
C. glutamicum ELB-P (see above and Fig. 2) was
employed for succinate production (S. Wieschalka and B.
J. Eikmanns, unpublished). Due to the inactivation of the
PDHC, PQO, and LDH, this strain does not form signifi-
cant amounts of acetate or lactate as by-products under
any aerobic and anaerobic condition tested (Wieschalka
et al., 2012). In contrast to the two-stage processes
described above (i.e. aerobic growth in complex or
minimal media and, after harvest of the cells and resus-
pension in new medium, transfer to sealed bottles or
fermenters respectively; Okino et al., 2008a; Litsanov
et al., 2012b), a one-stage fed-batch fermentation
process with C. glutamicum ELB-P was established, com-
bining biomass formation and succinate production in a
single bioreactor. This process includes three phases: (i)
an aerobic growth phase on glucose plus acetate, (ii) a
self-induced microaerobic phase at the end of the expo-
nential growth by minimal aeration, and (iii) an anaerobic
production phase, realized by gassing the fermenter with
CO2 (Fig. 4). This optimized process led to growth-
decoupled succinate production of more than 330 mM
(i.e. 39 g l-1) with a YP/S of 1.02 mol succinate per mol of
glucose. The final YP/S obtained, together with the forma-
tion of pyruvate (about 30 mM) as by-product, however,
still indicates a limitation, which might be overcome by
increasing the carbon flux from PEP/pyruvate to OAA or
by integration of the M. vaccae fdh gene and the use of
formate as an additional substrate for reduction equiva-
lents, as described above by Litsanov and colleagues
(2012b).
The experimental setup of a one-stage process (con-
secutive aerobic growth and anaerobic production in a
single bioreactor) as done with C. glutamicum ELB-P, see
above) represents an industrially feasible process.
However, a recent study on isobutanol production with
C. glutamicum disclosed the differences in the production
performance between two-stage fermentations (aerobic
growth in complex or minimal media and anaerobic pro-
duction in different containments, see above) and one-
stage fermentations in a single bioreactor: The isobutanol
YP/S in the one-stage fermentation was significantly lower
(0.48 mol vs 0.77 mol of isobutanol per mol of glucose),
indicating that the transition from the aerobic environment
(growth phase) to the anaerobic environment (production
phase) has a strong impact on the overall production
behaviour (Blombach and Eikmanns, 2011; Blombach
et al., 2011). Similarly, Martínez and colleagues (2010)
recently observed that introducing a microaerobic phase
at the end of the aerobic growth phase of an E. coli
succinate-producer led to an adjustment of the enzymatic
machinery and to improved succinate production under
anaerobic conditions. To our knowledge, the physiological
changes of C. glutamicum during a (slow or fast) shift from
aerobic to anaerobic conditions have so far not been
investigated. However, it can be foreseen that the insight
into the metabolic adaptation of the cells to such alter-
nating culture conditions will help to further optimize
organic acid production by novel metabolic engineering
approaches and also by applying optimally adapted
process conditions.
The YP/S of the most efficient E. coli strains produc-
ing succinate under anaerobic conditions, E. coli
SBS550MG/pHL413 and E. coli KJ134, were 1.60 mol
and 1.53 mol succinate per mol of glucose respectively
(Sánchez et al., 2005; Jantama et al., 2008; Table 1).
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Thus, both recombinant E. coli strains and in particular,
C. glutamicum BOL-3/pAN6-gap (Table 1) showed higher
YP/S than all known natural succinate-producing bacteria,
such as Anaerospirillium succiniproducens (1.37 mol-
mol-1 of glucose; Glassner and Datta, 1992) or Mannhe-
imia succiniproducens (1.16 mol mol-1 glucose; Lee et al.,
2006). A further advantage of employing the recombinant
C. glutamicum or E. coli strains is the potential use of
mineral media, keeping production and purification costs
lower than with Mannheimia or Anaerospirillum, which
both require complex media. C. glutamicum BOL-3/pAN6-
gap and C. glutamicum R DldhA pCRA717 produced
about threefold higher succinate titres than E. coli
SBS550MG/pHL413 (Table 1) and thus, Corynebacterium
seems to be the superior organism for succinate
production.
Very recently, Litsanov and colleagues (2012a)
reported also on aerobic succinate production with
C. glutamicum for the first time. Deletion of the SDH
genes initiated aerobic succinate production in C. glutami-
cum via glycolysis, PEP and/or pyruvate carboxylation,
the oxidative branch of the TCA cycle, and the glyoxylate
shunt. Acetate formation was mostly prohibited by shut-
down of the known pathways for acetate synthesis, result-
ing in C. glutamicum BL-1 (genotype: DsdhCAB, Dcat,
Dpqo, Dpta-ack; Litsanov et al., 2012a). To reduce carbon-
loss into cell mass, nitrogen-limited growth conditions
were established, forcing the cells into a resting state after
a certain period. With additional, plasmid-bound overpro-
duction of both PEPCx and the PCxP458S-variant, final
succinate titres and YP/S of up to 90 mM and 0.45 mol
succinate per mol of glucose, respectively, were observed
Fig. 3. Schematic presentation of the central
carbon metabolism of C. glutamicum BOL-3/
pAN6-gap during anaerobic succinate produc-
tion. For most abbreviations see legend to
Fig. 1. Further abbreviations: BCAAs,
branched-chain amino acids; LdhA, NAD+-
dependent L-lactate dehydrogenase; SucE,
succinate exporter; TCA, tricarboxylic acid.
Dark ellipses indicate homologous/
heterologous enzymes, crosses indicate inac-
tivation of the enzyme by deletion of the
respective gene. Dotted arrows indicate path-
ways not present due to gene inactivation,
grey arrows indicate pathways not used in
C. glutamicum BOL-3/pAN6-gap.
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(Litsanov et al., 2012a; Table 1). Concerning the specific
productivity of 1.6 mmol g(CDW)-1 h-1, C. glutamicum BL-1/
pAN6-pycP458Sppc showed the highest value described so
far for aerobic succinate production from glucose with
bacteria.
In comparison to other bacterial succinate producers,
C. glutamicum BL-1/pAN6-pycP458Sppc is exceedingly
competitive in aerobic succinate production (Table 1). Lin
and colleagues (2005) described various E. coli strains
approaching the maximal theoretical YP/S of about 1 mol
succinate per mol of glucose under aerobic conditions.
Corynebacterium glutamicum BL-1/pAN6-pycP458Sppc did
not reach this high YP/S, but the recombinant C. glutami-
cum strains produced significantly higher final succinate
titres in minimal instead of complex media (Table 1).
Production of organic acids with C. glutamicum
from alternative substrates
Economical relevant and sustainable production of
organic acids with microorganisms in an industrial scale
is dependent on the use of low-cost carbon sources, in
particular from renewable resources. So far, we focused
in this review on the fermentative organic acid production
from pretreated and purified carbon sources, such as
glucose and glucose plus formate, since the most prom-
ising attempts to produce organic acids with C. glutami-
cum were made with these substrates. To simplify
feedstock purchase and to improve the economic effi-
ciency, utilization of alternative, crude materials is of
great interest. However, C. glutamicum naturally cannot
utilize certain industrially relevant substrates, such as
glycerol, starch (from corn, wheat, rice, or potato), whey,
straw, or hemi- and lignocellulose. Especially lignocellu-
lose, consisting largely of cellulose, hemicellulose, and
lignin, is a widely abundant and potentially attractive
source of renewable feedstock. Hemicellulose, consist-
ing mainly of glucose but also to a significant portion of
C5 sugars (xylose and arabinose) (Wiselogel et al., 1996;
Aristidou and Penttilä, 2000), can be depolymerized by
chemical or enzymatic processes, and the resulting
sugar mixtures are also of interest as alternative feed-
stock for C. glutamicum. Whereas some organisms (e.g.
E. coli) are naturally able to consume the majority of
sugars in the mixtures resulting from saccharification
from hemicellulose, C. glutamicum needs metabolic engi-
neering to expand the spectrum of sugars that can be
utilized. Thus, the extension of the substrate spectrum of
C. glutamicum to cheap, easily accessible and renew-
able monomeric and polymeric carbon sources is desired
and therefore, an ongoing field of intensive research
(Wendisch et al., 2006b; Blombach and Seibold, 2010;
Rumbold et al., 2010; Okano et al., 2010; Becker and
Wittmann, 2011).
Several attempts have been made to broaden the
natural substrate spectrum of C. glutamicum towards
Fig. 4. Growth, glucose consumption, and product formation (A) and acetate consumption and the course of the pO2 (B) during a representa-
tive pH-controlled tri-phasic fed-batch cultivation of C. glutamicum ELB-P in a 400 ml bioreactor with minimal medium, initially containing 4%
(w/v) glucose, 1% (w/v) acetate and 6 mM L-alanine. (A) , growth; , glucose; , pyruvate; , succinate; , malate; , lactate. (B) Black
line, pO2; grey line, acetate. Roman numerals indicate (I) aerobic growth phase, (II) self-induced microaerobic phase, and (III) oxygen depriva-
tion by CO2 gassing. The pO2 peak at the end of the microaerobic phase (marked with the asterisk in 4B) indicated the end of aerobic growth,
as O2 consumption stopped, leading to increasing DO in the medium. Immediately, aeration was replaced by CO2 sparging and the production
phase started. A batch of glucose at the beginning of phase III should ensure carbon availability for succinate production. At least five inde-
pendent fermentations were performed, showing comparable results.
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starch (Seibold et al., 2006; Tateno et al., 2007), whey
(Barret et al., 2004), rice straw and wheat bran hydro-
lysates (Gopinath et al., 2011), grass and corn silages
(Neuner et al., 2012), glucosides and D-cellobiose (Kotrba
et al., 2003), glycerol (Rittmann et al., 2008), amino sugars
(Gruteser et al., 2012; Uhde et al., 2012) or pentose
sugars for growth and for the production of amino acids or
other value-added products (Blombach and Seibold, 2010;
Jojima et al., 2010; Buschke et al., 2011; Schneider et al.,
2011; Gopinath et al., 2012). The first approaches to
extend the substrate spectrum especially for organic acid
production were performed by Kawaguchi and colleagues
(2006; 2008) and Sasaki and colleagues (2008; 2009).
Plasmid-bound introduction of the xylose isomerase and
xylulokinase genes (xylA and xylB respectively) from
E. coli into C. glutamicum R enabled both aerobic growth
on xylose as sole carbon source and production of L-lactate
and succinate with resting cells under oxygen deprivation
conditions (Kawaguchi et al., 2006). Although the sugar
consumption rate and the specific productivity of the
recombinant C. glutamicum CRX2 was lower with
xylose than with glucose, the YP/S for succinate was even
higher on xylose (0.42 mol mol-1) than on glucose
(0.23 mol mol-1). In contrast, the YP/S for L-lactate was
lower with xylose as substrate (1.06 and 1.36 mol mol-1
respectively; Kawaguchi et al., 2006). A similar behaviour
was shown for succinate and L-lactate production from
arabinose with C. glutamicum CRA1, which expresses the
E. coli genes araA, araB and araD (encoding L-arabinose
isomerase, L-ribulokinase, and L-ribulose-5-phosphate
4-epimerase respectively) and therefore is able to metabo-
lize this C5 sugar (Kawaguchi et al., 2008). In this case,
with 200 mM arabinose as substrate, the YP/S for succinate
and L-lactate were 0.67 mol mol-1 and 0.75 mol mol-1
respectively (Kawaguchi et al., 2008).
Co-utilization of different C5 sugars with C6 sugars was
investigated to study catabolite repression effects in
C. glutamicum and to expand sugar utilization on condi-
tioned hemi- and lignocellulosic biomass hydrolysates
(Sasaki et al., 2008). These efforts resulted in a
C. glutamicum strain harbouring xylA and xylB as well as
bglFV317A and bglA (encoding PTS b-glucoside-specific
enzyme IIBCA component and phospho-b-glucosidase
respectively). This strain produced from a mixture of
D-cellobiose (10 g l-1), glucose (40 g l-1), and D-xylose
(20 g l-1) about 460 mM L-lactate, 110 mM succinate, and
30 mM acetate under anaerobic conditions, with a com-
bined yield of 0.85 g acids per g of sugar (Sasaki et al.,
2008). A combined strain, containing all named modifica-
tions for D-xylose, L-arabinose and D-cellobiose consump-
tion, and additionally overexpressing the arabinose
transporter gene araE from C. glutamicum ATCC31831,
was even able to consume glucose (35 g l-1), D-xylose
(17.5 g l-1), L-arabinose (7 g l-1), and cellobiose (7 g l-1)
simultaneously and completely under oxygen-deprived
conditions within 14 h (Sasaki et al., 2009).
Recently, Sasaki and colleagues (2011) developed a
C. glutamicum strain overexpressing the mannose
6-phosphate isomerase and fructose permease genes
manA and ptsF respectively. This strain consumed
mannose and glucose simultaneously and produced
about 400 mM L-lactate, 100 mM succinate and 30 mM
acetate from a sugar mixture of 200 mM glucose and
100 mM mannose under oxygen deprivation conditions
(Sasaki et al., 2011).
Litsanov and colleagues (2012c) very recently showed
aerobic succinate production with glycerol as sole carbon
source, by plasmid-bound transfer of the glycerol utilizing
genes glpFKD from E. coli into C. glutamicum BL-1. Glyc-
erol is a main by-product of biodiesel and bioethanol
production (Yazdani and Gonzalez, 2007) and using this
carbon source for the production of value-added chemi-
cals (such as succinate), the economic efficiency of these
biofuel production processes can be increased (Wendisch
et al., 2011). Plasmid pVWEx1-glpFKD has previously
been shown to enable growth and amino acid produc-
tion of C. glutamicum on glycerol as sole carbon
source (Rittmann et al., 2008). Consequently, using the
conditions established for C. glutamicum BL-1/pAN6-
pycP458Sppc (see above), C. glutamicum BL-1 (pVWEx1-
glpFKD) aerobically produced up to 79 mM succinate
(9.3 g l-1) with a YP/S of 0.21 mol per mol of glycerol (Lit-
sanov et al., 2012c). The specific succinate productivity of
C. glutamicum BL-1 pVWEx1-glpFKD on glycerol was as
high as for C. glutamicum BL-1/pAN6-pycP458Sppc on
glucose with 1.6 mmol g(CDW)-1 h-1. However, the volumet-
ric productivity of 3.59 mM h-1 is the highest productivity
so far described for aerobic succinate production (Litsa-
nov et al., 2012c; Table 1).
In summary, the above mentioned studies showed the
feasibility to expand the substrate spectrum of C. glutami-
cum to the main C5 and C6 sugars found in agricultural
residues, in hydrolysed hemicellulose and lignocellulosic
biomass, and to glycerol. For directed production of
organic acids from hemicellulose feedstock, the modifica-
tions made for broadening the substrate spectrum and
those made for optimal carbon flux to a desired organic
acid must be combined. The successful aerobic produc-
tion of succinate from glycerol instead of glucose by intro-
duction of the glycerol utilizing genes from E. coli to
C. glutamicum (Litsanov et al., 2012c; see above), is
one such example and promises the feasibility of such
approaches.
Summary and outlook
Driven by old and new knowledge and genome-based
metabolic and genetic engineering strategies, C. glutami-
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cum has become a major candidate as platform organism
for bio-based, industrial production of a variety of organic
acids from renewable biomass. As outlined above and
highlighted in Table 1, titres, YP/S, and productivities of
recently developed C. glutamicum producer strains are
highly competitive, in several cases already superior in
comparison to other bacterial, well-established production
systems. From current studies on transcriptome, pro-
teome, metabolome, and intracellular fluxes (Vertes et al.,
2012), from recent advances in evolutionary engineering
tools (Becker and Wittmann, 2011), and from recent
development of plasmid addiction systems (Schneider
et al., 2012) and of single cell approaches (Binder et al.,
2012; Mustafi et al., 2012), it can be expected that a
variety of further metabolic (or genetic) targets for strain
development/improvement will be identified in C. glutami-
cum. Future approaches to optimize organic acid produc-
tion certainly will not only aim at substrate flexibility (low
cost and eco-efficient feedstocks), product extension (e.g.
fumarate, malate, or itaconate), and/or the paths from a
substrate or substrate mixtures to the desired products
(i.e. substrate uptake, central metabolism, precursor
supply, synthetic pathways, and export of the respective
organic acid). They will also focus on maintenance of a
well-balanced redox state within the cells, on optimal
adaptation of the cells to alternating culture conditions
(e.g. shift from aerobic to anaerobic conditions), on strain
robustness, and on an increased acid-resistance of the
producer strains. Tolerance to organic acid stress repre-
sents a highly relevant factor for process design and
downstream processing of large-scale production proc-
esses, since organic acid recovery from low pH fermen-
tation broth in general is more cost-efficient than from
neutral broth. However, the achievements obtained in the
last 6 years and the wealth of new knowledge about the
physiology, the metabolism and its regulation, and the
proven production capabilities of C. glutamicum bode well
for the implementation of this organism as a platform for
new and even more (cost-)efficient processes for the pro-
duction of a variety of organic acids and also of other
specialty, fine and bulk chemicals.
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